.png)
World AIDS Vaccine Day 2025: Why HIV Testing Saves Lives
- James Hadland
- 1 day ago
- 5 min read
Every year on 18th May, World AIDS Vaccine Day marks a global commitment to finding a safe and effective HIV vaccine. But while the search for a vaccine continues, there's something everyone can do today that saves lives: get tested for HIV.
In the UK, new HIV cases rose by 46% in 2023 compared to 2022, a sharp reminder that HIV is still with us; and testing remains the first and most powerful step in breaking the chain of transmission (European Centre for Disease Prevention and Control, 2024).
This year's awareness day offers a timely opportunity to highlight the vital role of HIV and AIDS testing in prevention, early treatment, and ending stigma.
Why HIV Testing Matters
Early Diagnosis Saves Lives
Many people with HIV are unaware they are infected. Without testing, they miss out on life-saving treatments and may unknowingly transmit the virus to others. When HIV is diagnosed early, antiretroviral therapy (ART) can suppress the virus to undetectable levels, meaning it cannot be passed on sexually and allows individuals to live long, healthy lives (UNAIDS, 2023).
ART doesn’t cure HIV, but it turns it into a manageable condition. With consistent use, people living with HIV can expect a normal life expectancy and lead active, fulfilling lives. This medical progress means early testing truly is a gateway to health and longevity.
A Key Step for High-Risk Groups
Testing is especially important for sexually active people, men who have sex with men, people who inject drugs, and others in high-prevalence communities. The World Health Organisation urges targeted HIV testing in these groups to reduce late diagnoses and improve access to care (Tatoud et al., 2025).
For those in higher-risk groups, regular testing provides peace of mind and ensures timely access to treatment if needed. It’s about empowering individuals to take control of their health and protect others around them.
Breaking the Stigma
Despite decades of awareness campaigns, stigma around HIV and testing still exists. Misconceptions about who gets HIV or how it's spread prevent many people from getting tested.
Testing should be seen as a routine, responsible part of health care, similar to cervical screenings or cholesterol checks. UK clinics offer non-judgmental, confidential environments where anyone can get tested, with results typically available within minutes (NHS, 2024).
Tackling stigma means changing the narrative. Getting tested isn’t something to be ashamed of—it’s a powerful act of self-respect and compassion for others. Open conversations help dismantle outdated fears and normalise testing.
Testing Options and Access in the UK
In the UK, there are a variety of ways to get tested for HIV:
GP Surgeries and Sexual Health Clinics – Free, confidential HIV and STI testing is widely available.
Home Test Kits – Discreet and easy-to-use HIV kits for testing at home can be ordered online through the NHS or private providers.
Community Outreach – Mobile testing units and community centres offer rapid testing, especially in urban areas and Pride events.
By increasing the availability and visibility of testing services, we can encourage more people to get tested for HIV regularly.
Home test kits offer a flexible, private option. They’re ideal for those who may feel uncomfortable visiting a clinic. The key is to make testing accessible and approachable for everyone.
Hope on the Horizon: The HIV Vaccine Effort
While testing and treatment remain vital, scientific progress continues in the quest for a vaccine.
Recent Setbacks and Future Directions
The Mosaico trial, a major Phase 3 HIV vaccine study, was recently discontinued after failing to demonstrate effectiveness in preventing infection (Adepoju et al., 2025). The vaccine could not induce broadly neutralising antibodies (bNAbs), a key requirement for protection against diverse HIV strains.
bNAbs are special types of antibodies that can recognise and block many different strains of HIV. The Mosaico trial hoped to generate these, but unfortunately, the immune response wasn’t strong or broad enough to be effective.
However, researchers are now developing next-generation strategies using virus-like particles, SOSIP trimers, nanoparticles, and mRNA platforms—the same technology used in COVID-19 vaccines—to address these shortcomings (Adepoju et al., 2025; Scott & Worku, 2024).
Put simply, scientists are now focusing on smarter vaccine designs that teach the immune system how to recognise HIV's most vulnerable parts. These new platforms offer more precise targeting and potentially stronger protection.
Artificial intelligence (AI) is also being used to design better vaccines faster. AI helps researchers predict which parts of the virus to target, speeding up development and increasing the chances of success (Adepoju et al., 2025).
Think of AI as a vaccine detective. It helps researchers sift through huge amounts of data to identify the best possible ways to train our immune systems to fight HIV. It's still early days, but the potential is enormous.
Why Testing Still Matters
Despite advances in vaccine science, testing and treatment remain essential tools. Even with a partially effective vaccine, people will still need to know their status to access care, protect partners, and monitor their health (Tatoud et al., 2025).
As highlighted by European researchers, the integration of vaccine efforts with ongoing prevention and treatment strategies will be key to bringing the epidemic under control (Tatoud et al., 2025).
Vaccines are just one part of the puzzle. Until a highly effective one is widely available, HIV testing is still the most powerful way to stop the spread and get people the support they need.
Take Action This World AIDS Vaccine Day
Get tested for HIV, especially if it's been a while.
Encourage friends and loved ones to get tested.
Use NHS services or trusted private clinics for confidential testing.
Speak openly to break the stigma.
Support ongoing vaccine research and learn about the science behind it.
If you're unsure where to start, visit our STI testing page for more information and to book your discreet HIV and STI blood test.
At Health Klinix, we're here to support your journey to better health. Whether it’s through routine screening or specialist advice, our friendly team is ready to help.
Sources and References
Adepoju, V.A.; Udah, D.C.; Onyezue, O.I.; Adnani, Q.E.S.; Jamil, S.; Bin Ali, M.N. Navigating the Complexities of HIV Vaccine Development: Lessons from the Mosaico Trial and Next-Generation Development Strategies. Vaccines 2025, 13, 274. https://doi.org/10.3390/vaccines13030274
Scott, G.Y., & Worku, D. (2024). HIV vaccination: Navigating the path to a transformative breakthrough—A review of current evidence. Health Sci Rep, 7:e70089. https://doi.org/10.1002/hsr2.70089
Tatoud, R., et al. (2025). In danger: HIV vaccine research and development in Europe. PLOS Global Public Health, 5(4):e0004364. https://doi.org/10.1371/journal.pgph.0004364
UNAIDS. (2023). The End of the Mosaico Vaccine Trial Must Be a Spur to Deliver HIV treatment and Prevention Options to All Who Need Them.
NHS. (2024). HIV and AIDS – Testing and Treatment. Retrieved from https://www.nhs.uk/conditions/hiv-and-aids/
European Centre for Disease Prevention and Control. (2024). HIV/AIDS Surveillance in Europe – 2023 data. https://www.ecdc.europa.eu/en/publications-data/hiv-aids-surveillance-europe-2024-2023-data
Written by:
James Hadland, MPhil candidate, University of Cambridge
Approved by:
Dr Ravi Gowda, Consultant Physician, MBBS, MRCP(UK), DTM&H, MRCGP, DCH, DRCOG, DFFP